[1]
Maha Abdul Rahim Muhammad Othman, “Clinical Outcomes of SGLT2 Inhibitors in Heart Failure Patients Regardless of Diabetes Status: A Systematic Review”, IJSE, vol. 41, no. 22s, pp. 525–548, Sep. 2026.